Apolipoprotein E in synaptic plasticity and alzheimer’s disease: Potential cellular and molecular mechanisms

Jaekwang Kim, Hyejin Yoon, Jacob Basak, Jungsu Kim

Research output: Contribution to journalReview article

61 Citations (Scopus)

Abstract

Alzheimer’s disease (AD) is clinically characterized with progressive memory loss and cognitive decline. Synaptic dysfunction is an early pathological feature that occurs prior to neurodegeneration and memory dysfunction. Mounting evidence suggests that aggregation of amyloid-? (A?) and hyperphosphorylated tau leads to synaptic deficits and neurodegeneration, thereby to memory loss. Among the established genetic risk factors for AD, the ?4 allele of apolipoprotein E (APOE) is the strongest genetic risk factor. We and others previously demonstrated that apoE regulates A? aggregation and clearance in an isoform- dependent manner. While the effect of apoE on A? may explain how apoE isoforms differentially affect AD pathogenesis, there are also other underexplored pathogenic mechanisms. They include differential effects of apoE on cerebral energy metabolism, neuroinflammation, neurovascular function, neurogenesis, and synaptic plasticity. ApoE is a major carrier of cholesterols that are required for neuronal activity and injury repair in the brain. Although there are a few conflicting findings and the underlying mechanism is still unclear, several lines of studies demonstrated that apoE4 leads to synaptic deficits and impairment in long-term potentiation, memory and cognition. In this review, we summarize current understanding of apoE function in the brain, with a particular emphasis on its role in synaptic plasticity and the underlying cellular and molecular mechanisms, involving low-density lipoprotein receptor-related protein 1 (LRP1), syndecan, and LRP8/ApoER2.

Original languageEnglish (US)
Pages (from-to)833-840
Number of pages8
JournalMolecules and Cells
Volume37
Issue number11
DOIs
StatePublished - Nov 1 2014

Fingerprint

Neuronal Plasticity
Apolipoproteins E
Alzheimer Disease
Apolipoprotein E4
Memory Disorders
Protein Isoforms
Syndecans
Low Density Lipoprotein Receptor-Related Protein-1
Long-Term Memory
Long-Term Potentiation
Neurogenesis
Brain
Amyloid
Cognition
Energy Metabolism
Alleles
Cholesterol
Wounds and Injuries

Keywords

  • Alzheimer’s disease
  • ApoER2
  • Apolipoprotein E
  • HSPG
  • LRP1
  • Synaptic plasticity

ASJC Scopus subject areas

  • Medicine(all)
  • Molecular Biology
  • Cell Biology

Cite this

Apolipoprotein E in synaptic plasticity and alzheimer’s disease : Potential cellular and molecular mechanisms. / Kim, Jaekwang; Yoon, Hyejin; Basak, Jacob; Kim, Jungsu.

In: Molecules and Cells, Vol. 37, No. 11, 01.11.2014, p. 833-840.

Research output: Contribution to journalReview article

Kim, Jaekwang ; Yoon, Hyejin ; Basak, Jacob ; Kim, Jungsu. / Apolipoprotein E in synaptic plasticity and alzheimer’s disease : Potential cellular and molecular mechanisms. In: Molecules and Cells. 2014 ; Vol. 37, No. 11. pp. 833-840.
@article{8bf62b0531224b8bb9c1e2580904855a,
title = "Apolipoprotein E in synaptic plasticity and alzheimer’s disease: Potential cellular and molecular mechanisms",
abstract = "Alzheimer’s disease (AD) is clinically characterized with progressive memory loss and cognitive decline. Synaptic dysfunction is an early pathological feature that occurs prior to neurodegeneration and memory dysfunction. Mounting evidence suggests that aggregation of amyloid-? (A?) and hyperphosphorylated tau leads to synaptic deficits and neurodegeneration, thereby to memory loss. Among the established genetic risk factors for AD, the ?4 allele of apolipoprotein E (APOE) is the strongest genetic risk factor. We and others previously demonstrated that apoE regulates A? aggregation and clearance in an isoform- dependent manner. While the effect of apoE on A? may explain how apoE isoforms differentially affect AD pathogenesis, there are also other underexplored pathogenic mechanisms. They include differential effects of apoE on cerebral energy metabolism, neuroinflammation, neurovascular function, neurogenesis, and synaptic plasticity. ApoE is a major carrier of cholesterols that are required for neuronal activity and injury repair in the brain. Although there are a few conflicting findings and the underlying mechanism is still unclear, several lines of studies demonstrated that apoE4 leads to synaptic deficits and impairment in long-term potentiation, memory and cognition. In this review, we summarize current understanding of apoE function in the brain, with a particular emphasis on its role in synaptic plasticity and the underlying cellular and molecular mechanisms, involving low-density lipoprotein receptor-related protein 1 (LRP1), syndecan, and LRP8/ApoER2.",
keywords = "Alzheimer’s disease, ApoER2, Apolipoprotein E, HSPG, LRP1, Synaptic plasticity",
author = "Jaekwang Kim and Hyejin Yoon and Jacob Basak and Jungsu Kim",
year = "2014",
month = "11",
day = "1",
doi = "10.14348/molcells.2014.0248",
language = "English (US)",
volume = "37",
pages = "833--840",
journal = "Molecules and Cells",
issn = "1016-8478",
publisher = "Korean Society for Molecular and Cellular Biology",
number = "11",

}

TY - JOUR

T1 - Apolipoprotein E in synaptic plasticity and alzheimer’s disease

T2 - Potential cellular and molecular mechanisms

AU - Kim, Jaekwang

AU - Yoon, Hyejin

AU - Basak, Jacob

AU - Kim, Jungsu

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Alzheimer’s disease (AD) is clinically characterized with progressive memory loss and cognitive decline. Synaptic dysfunction is an early pathological feature that occurs prior to neurodegeneration and memory dysfunction. Mounting evidence suggests that aggregation of amyloid-? (A?) and hyperphosphorylated tau leads to synaptic deficits and neurodegeneration, thereby to memory loss. Among the established genetic risk factors for AD, the ?4 allele of apolipoprotein E (APOE) is the strongest genetic risk factor. We and others previously demonstrated that apoE regulates A? aggregation and clearance in an isoform- dependent manner. While the effect of apoE on A? may explain how apoE isoforms differentially affect AD pathogenesis, there are also other underexplored pathogenic mechanisms. They include differential effects of apoE on cerebral energy metabolism, neuroinflammation, neurovascular function, neurogenesis, and synaptic plasticity. ApoE is a major carrier of cholesterols that are required for neuronal activity and injury repair in the brain. Although there are a few conflicting findings and the underlying mechanism is still unclear, several lines of studies demonstrated that apoE4 leads to synaptic deficits and impairment in long-term potentiation, memory and cognition. In this review, we summarize current understanding of apoE function in the brain, with a particular emphasis on its role in synaptic plasticity and the underlying cellular and molecular mechanisms, involving low-density lipoprotein receptor-related protein 1 (LRP1), syndecan, and LRP8/ApoER2.

AB - Alzheimer’s disease (AD) is clinically characterized with progressive memory loss and cognitive decline. Synaptic dysfunction is an early pathological feature that occurs prior to neurodegeneration and memory dysfunction. Mounting evidence suggests that aggregation of amyloid-? (A?) and hyperphosphorylated tau leads to synaptic deficits and neurodegeneration, thereby to memory loss. Among the established genetic risk factors for AD, the ?4 allele of apolipoprotein E (APOE) is the strongest genetic risk factor. We and others previously demonstrated that apoE regulates A? aggregation and clearance in an isoform- dependent manner. While the effect of apoE on A? may explain how apoE isoforms differentially affect AD pathogenesis, there are also other underexplored pathogenic mechanisms. They include differential effects of apoE on cerebral energy metabolism, neuroinflammation, neurovascular function, neurogenesis, and synaptic plasticity. ApoE is a major carrier of cholesterols that are required for neuronal activity and injury repair in the brain. Although there are a few conflicting findings and the underlying mechanism is still unclear, several lines of studies demonstrated that apoE4 leads to synaptic deficits and impairment in long-term potentiation, memory and cognition. In this review, we summarize current understanding of apoE function in the brain, with a particular emphasis on its role in synaptic plasticity and the underlying cellular and molecular mechanisms, involving low-density lipoprotein receptor-related protein 1 (LRP1), syndecan, and LRP8/ApoER2.

KW - Alzheimer’s disease

KW - ApoER2

KW - Apolipoprotein E

KW - HSPG

KW - LRP1

KW - Synaptic plasticity

UR - http://www.scopus.com/inward/record.url?scp=84983071309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983071309&partnerID=8YFLogxK

U2 - 10.14348/molcells.2014.0248

DO - 10.14348/molcells.2014.0248

M3 - Review article

C2 - 25358504

AN - SCOPUS:84983071309

VL - 37

SP - 833

EP - 840

JO - Molecules and Cells

JF - Molecules and Cells

SN - 1016-8478

IS - 11

ER -